informCLL™: A Disease Registry for Patients with Chronic Lymphocytic Leukemia (PCYC-
PURPOSE OF THIS CLINICAL RESEARCH TRIAL
The purpose of the Inform CLL is to characterize and describe treatment patterns for those initiating treatment with approved oral kinase inhibitors and other approved anti-CLL therapies/regimens. This study also evaluates association of treatment patterns with patient characteristics, healthcare resource utilization and patient reported HRQoL.
MORE DETAILS ON THIS TRIAL
15005 / NCT02582879 / Open 2-29-15
TRIAL AVAILABLE AT THESE LOCATIONS: